Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position

Journal of Medicinal Chemistry

Volumn 45, Issue 26, 2002, Pages 5736-5744

  Holder, Jerry Ryan ^a   Xiang, Zhimin ^a   Bauzo, Rayna M ^a   Haskell Luevano, Carrie ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; PROOPIOMELANOCORTIN;

AMINO ACID SEQUENCE; ARTICLE; DNA LIBRARY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PEPTIDE SYNTHESIS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SUBSTITUTION; ANIMALS; LIGANDS; MELANOCYTE-STIMULATING HORMONES; MICE; OLIGOPEPTIDES; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPTOPHAN;

EID: 0037137613     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020296e     Document Type: Article

References (62)

1. Cone, R. D.; Lu, D.; Kopula, S.; Vage, D. I.; Klungland, H.; Boston, B.; Chen, W.; Orth, D. N.; Pouton, C.; Kesterson, R. A. The melanocortin receptors: Agonists, antagonists, and the hormonal control of pigmentation. Recent Progr. Hormone Res. 1996, 51, 287-318.
2. Pritchard, L. E.; Turnbull, A. V.; White, A. Pro-opiomelanocortin processing in the hypothalamus: Impact on melanocortin signaling and obesity. J. Endocrinol. 2002, 172, 411-421.
3. Hruby, V. J.; Wilkes, B. C.; Hadley, M. E.; Al-Obeidi, F.; Sawyer, T. K.; Staples, D. J.; DeVaux, A.; Dym, O.; Castrucci, A. M.; Hintz, M. F.; Riehm, J. P.; Rao, K. R. α-Melanotropin: The minimal active sequence in the frog skin bioassay. J. Med. Chem. 1987, 30, 2126-2130.
4. Castrucci, A. M. L.; Hadley, M. E.; Sawyer, T. K.; Wilkes, B. C.; Al-Obeidi, F.; Staples, D. J.; DeVaux, A. E.; Dym, O.; Hintz, M. F.; Riehm, J.; Rao, K. R.; Hruby, V. J. α-Melanotropin: The minimal active sequence in the lizard skin bioassay. Gen. Comput. Endocrinol. 1989, 73, 157-163.
5. Haskell-Luevano, C.; Sawyer, T. K.; Hendrata, S.; North, C.; Panahinia, L.; Stum, M.; Staples, D. J.; Castrucci, A. M.; Hadley, M. E.; Hruby, V. J. Truncation studies of α-melanotropin peptides identifies tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides 1996, 17, 995-1002.
6. Lu, D.; Willard, D.; Patel, I. R.; Kadwell, S.; Overton, L.; Kost, T.; Luther, M.; Chen, W.; Yowchik, R. P.; Wilkison, W. O.; Cone, R. D. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994, 371, 799-802.
7. Shutter, J. R.; Graham, M.; Kinsey, A. C.; Scully, S.; Lüthy, R.; Stark, K. L. Hypothalamic expression of ART, a novel gene related to Agouti, is up-regulated in obese and diabetic mutant mice. Genes Development 1997, 11, 593-602.
8. Ollmann, M. M.; Wilson, B. D.; Yang, Y.-K.; Kerns, J. A.; Chen, Y.; Gantz, I.; Barsh, G. S. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278, 135-138.
9. Chen, A. S.; Marsh, D. J.; Trumbauer, M. E.; Frazier, E. G.; Guan, X. M.; Yu, H.; Rosenblum, C. I.; Vongs, A.; Feng, Y.; Cao, L.; Metzger, J. M.; Strack, A. M.; Camacho, R. E.; Mellin, T. N.; Nunes, C. N.; Min, W.; Fisher, J.; Gopal-Truter, S.; MacIntyre, D. E.; Chen, H. Y.; Van Der Ploeg, L. H. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000, 26, 97-102.
10. Butler, A. A.; Kesterson, R. A.; Khong, K.; Cullen, M. J.; Pelleymounter, M. A.; Dekoning, J.; Baetscher, M.; Cone, R. D. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141, 3518-21.
11. Huszar, D.; Lynch, C. A.; Fairchild-Huntress, V.; Dunmore, J. H.; Smith, F. J.; Kesterson, R. A.; Boston, B. A.; Fang, Q.; Berkemeir, L. R.; Gu, W.; Cone, R. D.; Campfield, L. A.; Lee, F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88, 131-141.
12. Hruby, V. J.; Wilkes, B. C.; Cody, W. L.; Sawyer, T. K.; Hadley, M. E. Melanotropins: Structural, conformational and biological considerations in the development of superpotent and superprolonged analogues. Pept. Protein Rev. 1984, 3, 1-64.
13. Mountjoy, K. G.; Robbins, L. S.; Mortrud, M. T.; Cone, R. D. The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257, 1248-1251.
14. Lu, D.; Väge, D. I.; Cone, R. D. A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor. Mol. Endocrinol. 1998, 12, 592-604.
15. Chen, W.; Kelly, M. A.; Opitz-Araya, X.; Thomas, R. E.; Low, M. J.; Cone, R. D. Exocrine gland dysfunction In MC5-R deficient mice: Evidence For coordinated regulation of exocrine gland functions by melanocortin peptides. Cell 1997, 91, 789-798.
16. Yang, Y.; Fong, T. M.; Dickinson, C. J.; Mao, C.; Li, J. Y.; Tota, M. R.; Mosley, R.; Van Der Ploeg, L. H.; Gantz, I. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 2000, 39, 14900-14911.
17. Al-Obeidi, F.; Hadley, M. E.; Pettitt, B. M.; Hruby, V. J. Design of a new class of superpotent cyclic α-melanotropins based on quenched dynamic stimulations. J. Am. Chem. Soc. 1989, 111, 3413-3416.
18. Al-Obeidi, F.; Castrucci, A. M.; Hadley, M. E.; Hruby, V. J. Potent and prolonged acting cyclic lactam analogues of α-melanotropin: Design based on molecular dynamics. J. Med. Chem. 1989, 32, 2555-2561.
19. Bednarek, M. A.; Macneil, T.; Kalyani, R. N.; Tang, R.; Van der Ploeg, L. H.; Weinberg, D. H. Analogues of MTII, lactam derivatives of α-melanotropin, modified at the N-terminus, and their selectivity at human melanocortin receptors 3, 4, and 5. Biochem. Biophys. Res. Commun. 1999, 261, 209-213.
20. Bednarek, M. A.; Silva, M. V.; Arison, B.; MacNeil, T.; Kalyani, R. N.; Huang, R. R.; Weinberg, D. H. Structure-function studies on the cyclic peptide MT-II, lactam derivative of α-melanotropin. Peptides 1999, 20, 401-409.
21. Bednarek, M. A.; MacNeil, T.; Kalyani, R. N.; Tang, R.; Van Der Ploeg, L. H.; Weinberg, D. H. Selective, high affinity peptide antagonists of α-melanotropin action at human melanocortin receptor 4: Their synthesis and biological evaluation in vitro. J. Med. Chem. 2001, 44, 3665-3672.
22. Bednarek, M. A.; MacNeil, T.; Tang, R.; Kalyani, R. N.; Van der Ploeg, L. H.; Weinberg, D. H. Potent and selective peptide agonists of alpha-melanotropin action at human melanocortin receptor 4: Their synthesis and biological evaluation in vitro. Biochem. Biophys. Res. Commun. 2001, 286, 641-645.
23. Haskell-Luevano, C.; Lim, S.; Yuan, W.; Cone, R. D.; Hruby, V. J. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions. Peptides 2000, 21, 49-57.
24. Haskell-Luevano, C.; Sawyer, T. K.; Trumpp-Kallmeyer, S.; Bikker, J.; Humblet, C.; Gantz, I.; Hruby, V. J. Three-dimensional molecular models of the hMCIR melanocortin receptor: Complexes with melanotropin peptide agonists. Drug Des. Discovery 1996, 14, 197-211.
25. Haskell-Luevano, C. In vitro mutagenesis studies of melanocortin receptor coupling and ligand binding. In The Melanocortin Receptors; R. D. Cone, Eds.; The Humana Press Inc.: New Jersey, 2000; pp 263-306.
26. Haskell-Luevano, C.; Cone, R. D.; Monck, E. K.; Wan, Y.-P. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: Identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 2001, 40, 6164-6179.
27. 7] melanocyte stimulating hormone with the human melanocortin-1 receptor (Melanocyte α-MSH Receptor). J. Biol. Chem. 1997, 272, 23000-23010.
28. Stewart, J. M.; Young, J. D. Solid-Phase Peptide Synthesis, 2nd Ed.; Pierce Chemical Co.: Rockford, IL, 1984.
29. Haskell-Luevano, C.; Holder, J. R.; Monck, E. K.; Bauzo, R. M. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors. J. Med. Chem. 2001, 44, 2247-2252.
30. Kazmierski, W.; Hruby, V. J. A New approach to receptor ligand design: Synthesis and conformation of a new class of potent and highly selective opioid antagonists utilizing tetrahydroisoouinoline carboxylic acid. Tetrahedron 1988, 14, 697-710.
31. Kazmierski, W. M.; Yamamura, H. I.; Hruby, V. J. Topographic design of peptide neurotransmitters and hormones on stable backbone Templates: Relation of Conformation and Dynamics to Bioactivity. J. Am. Chem. Soc. 1991, 113, 2275-2283.
32. Kazmierski, W. M.; Ferguson, R. D.; Lipowski, A. W.; Hurby, V. J. A topogrpahical model of μ-opiod and brain somatostatin receptor selective ligands. Int. J. Pept. Protein Res. 1995, 46, 265-278.
33. Chhajlani, V.; Wikberg, J. E. S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 1992, 309, 417-420.
34. Sahm, U. G.; Olivier, G. W. J.; Branch, S. K.; Moss, S. H.; Pouton, C. W. Synthesis and biological evaluation of α-MSH analogues substituted with alanine. Peptides 1994, 15, 1297-1302.
35. Boteju, L. W.; Wegner, K.; Hruby, V. J. Asymmetric synthesis of unusual amino acids: Synthesis of the optically pure isomers of indole-protected β-methyltryptophan suitable for peptide synthesis. Tetrahedron Lett. 1992, 33, 7491-7494.
36. Boteju, L. W.; Wegner, K.; Qian, X.; Hruby, V. J. Asymmetric synthesis of unusual amino acids: Synthesis of optically pure isomers of N-indole-(2-mesitylenesulfonyl)-β-methyltrypotphan. Tetrahedron 1994, 50, 2391-2404.
37. Haskell-Luevano, C.; Boteju, L. W.; Hruby, V. J. Removal of the N-Indole-(Mesitylenesulfonyl) protecting group using HF cleavage conditions. Lett. Pept. Sci. 1995, 1, 163-170.
38. Haskell-Luevano, C.; Boteju, L. W.; Miwa, H.; Dickinson, C.; Gantz, I.; Yamada, T.; Hadley, M. E.; Hruby, V. J. Topographical modifications of melanotropin peptide analogues with β-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities. J. Med. Chem. 1995, 38, 4720-4729.
39. 9 melanotropin side chain pharmacophores affect ligand-receptor interactions and prolonged biological activity. J. Med. Chem. 1997, 40, 2740-2749.
40. Hruby, V. J.; Li, G.; Haskell-Luevano, C.; Shenderovich, M. Design of peptides, proteins, and peptidomimetics in Chi space. Biopolym., Pept. Sci. 1997, 43, 219-266.
41. Roselli-Rehfuss, L.; Mountjoy, K. G.; Robbins, L. S.; Mortrud, M. T.; Low, M. J.; Tatro, J. B.; Entwistle, M. L.; Simerly, R. B.; Cone, R. D. Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 8856-8860.
42. Gantz, I.; Konda, Y.; Tashiro, T.; Shimoto, Y.; Miwa, H.; Munzert, G.; Watson, S. J.; DelValle, J.; Yamada, T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 1993, 268, 8246-8250.
43. Bednarek, M. A.; MacNeil, T.; Kalyani, R. N.; Tang, R.; Van der Ploeg, L. H.; Weinberg, D. H. Analogues of lactam derivatives of α-melanotropin with basic and acidic residues. Biochem. Biophys. Res. Commun. 2000, 272, 23-28.
44. Fan, W.; Boston, B. A.; Kesterson, R. A.; Hruby, V. J.; Cone, R. D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385, 165-168.
45. Mergen, M.; Mergen, H.; Ozata, M.; Oner, R.; Oner, C. Rapid communication: A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J. Clin. Endocrinol. Metab. 2001, 86, 3448-3451.
46. Vaisse, C.; Clement, K.; Guy-Grand, B.; Froguel, P. A Frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 1998, 20, 113-114.
47. Vaisse, C.; Clement, K.; Durand, E.; Hercberg, S.; Guy-Grand, B.; Froguel, P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 2000, 106, 253-262.
48. Farooqi, I. S.; Yeo, G. S.; Keogh, J. M.; Aminian, S.; Jebb, S. A.; Butler, G.; Cheetham, T.; O'Rahilly, S. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest. 2000, 106, 271-279.
49. Sina, M.; Hinney, A.; Ziegler, A.; Neupert, T.; Mayer, H.; Siegfried, W.; Blum, W. F.; Remschmidt, H.; Hebebrand, J. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am. J. Hum. Genet. 1999, 65, 1501-1507.
50. Hinney, A.; Schmidt, A.; Nottebom, K.; Heibult, O.; Becker, I.; Ziegler, A.; Gerber, G.; Sina, M.; Gorg, T.; Mayer, H.; Siegfried, W.; Fichter, M.; Remschmidt, H.; Hebebrand, J. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 1999, 84, 1483-1486.
51. Gantz, I.; Shimoto, Y.; Konda, Y.; Miwa, H.; Dickinson, C. J.; Yamada, T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 1994, 200, 1214-1220.
52. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 1995, 38, 3454-3461.
53. Sawyer, T. K.; Sanfillippo, P. J.; Hruby, V. J.; Engel, M. H.; Heward, C. B.; Burnett, J. B.; Hadley, M. E. 4-Norleucine, 7-d-phenylalanine-α-melanocyte-stimulating hormone: A highly potent α-melanotropin with ultra long biological activity. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 5754-5758.
54. 2 at the mouse melanocortin receptors: Part 2 modifications at the Phe position. J. Med. Chem. 2002, 45, 3073-3081.
55. The Melanocortin Receptors; Cone, R. D., Ed.; The Humana Press Inc.: NJ, 2000.
56. Grieco, P.; Han, G.; Weinberg, D.; Van der Ploeg, L. H.; Hruby, V. J. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. Biochem. Biophys. Res. Commun. 2002, 292, 1075-1080.
57. Danho, W.; Swistok, J.; Cheung, A.; Chu, Y.-J.; Wang, Y.; Chen, L.; Bartkovitz, D.; Gore, V.; Qi, L.; Fry, D.; Greeley, D.; Sun, H.; Guenot, J.; Franco, L.; Kurylko, G.; Rumennik, L.; Yagaloff, K. Highly selective cyclic peptides for human melanocortin-4 receptor (MC-4 R): Design, synthesis, bioactive conformation, and pharmacological evaluation as an anti-obesity agent. In Proceedings of the 2nd International/17th American Peptide Symposium; H. Lebel M., R., Eds.; Kluwer Academic Publishers: The Netherlands, 2001; pp 701-703.
58. 2 at the mouse melanocortin receptors: I Modifications at the his position. J. Med. Chem. 2002, 45, 2801-2810.
59. Benoit, S. C.; Schwartz, M. W.; Lachey, J. L.; Hagan, M. M.; Rushing, P. A.; Blake, K. A.; Yagaloff, K. A.; Kurylko, G.; Franco, L.; Danhoo, W.; Seeley, R. J. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. J. Neurosci. 2000, 20, 3442-3448.
60. Kavarana, M. J.; Trivedi, D.; Cai, M.; Ying, J.; Hammer, M.; Cabello, C.; Grieco, P.; Han, G.; Hruby, V. J. Novel cyclic templates of α-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. J. Med. Chem. 2002, 45, 2644-2650.
61. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970, 34, 595-598.
62. Chen, W.; Shields, T. S.; Stork, P. J. S.; Cone, R. D. A Colorimetric assay for measuring activation of Gs- and Gq-Coupled signaling pathways. Anal. Biochem. 1995, 226, 349-354.